Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tradr 2X Long Snps Daily ETF (SNPX)

Tradr 2X Long Snps Daily ETF (SNPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Tradr ETFs
  • Assets Under Management 1,614,600
  • Shares Outstanding, K 60
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 1.30%

Options Overview Details

View History
  • Implied Volatility 89.96% (-4.11%)
  • Historical Volatility 97.56%
  • IV Percentile 48%
  • IV Rank 58.15%
  • IV High 112.22% on 02/17/26
  • IV Low 59.02% on 12/22/25
  • Expected Move (DTE 15) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 4
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 106
  • Open Int (30-Day) 67
  • Expected Range 26.91 to 26.91

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.72 +13.45%
on 02/27/26
30.07 -10.51%
on 02/25/26
+0.75 (+2.87%)
since 02/04/26
3-Month
23.72 +13.45%
on 02/27/26
43.54 -38.19%
on 01/12/26
-6.47 (-19.38%)
since 12/04/25

Most Recent Stories

More News
Trade 3 Stocks Driving the $500B AI Infrastructure Boom with 2X Leverage

Tradr ETFs has launched three new 2X leveraged ETFs (LITX, CSEX, and SNPX) to help active traders amplify daily exposure to infrastructure leaders Lumentum, Celestica, and Synopsys as they he

LITX : 94.20 (-3.49%)
SNPX : 26.91 (+2.75%)
SNPS : 430.98 (+1.57%)
CLS : 270.64 (+5.33%)
CSEX : 13.03 (+10.61%)
LITE : 680.80 (-1.96%)
Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

Newly listed options deliver another tool for traders to express their views on BE, CLS, NNE & SNPS

BEX : 27.58 (+14.16%)
SNPX : 26.91 (+2.75%)
NNEX : 9.89 (+2.23%)
CSEX : 13.03 (+10.61%)
Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

Four funds represent first-to-market strategies offering 200% exposure on trending growth stocks

BEX : 27.58 (+14.16%)
SNPX : 26.91 (+2.75%)
NNEX : 9.89 (+2.23%)
CSEX : 13.03 (+10.61%)
Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for...

SNPX : 26.91 (+2.75%)
Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 26.91 (+2.75%)
Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 26.91 (+2.75%)
Pre-Market Brief: Stocks Mixed As Recession, Rate Hike Fears Persist

March S&P 500 futures (ESH23) are trending up +0.39% this morning after three major U.S. benchmark indices slid for a third successive session and suffered a second consecutive week of losses on Friday...

TSLA : 405.94 (+3.44%)
HEXO : 0.7100 (+2.45%)
SNPX : 26.91 (+2.75%)
CTLT : 63.48 (unch)
ESH23 : 3,957.05s (-0.09%)
ARDX : 6.65 (+6.91%)
Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 26.91 (+2.75%)
Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

SNPX : 26.91 (+2.75%)
Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...

SNPX : 26.91 (+2.75%)

Fund Summary

The Tradr 2X Long SNPS Daily ETF seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Synopsys, Inc. (NASDAQ: SNPS). The Fund does not seek to achieve its stated investment objective for a period of time different...

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 29.73
2nd Resistance Point 28.75
1st Resistance Point 27.83
Last Price 26.91
1st Support Level 25.93
2nd Support Level 24.95
3rd Support Level 24.03

See More

52-Week High 43.54
Fibonacci 61.8% 35.46
Fibonacci 50% 32.97
Fibonacci 38.2% 30.48
Last Price 26.91
52-Week Low 22.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar